Recruiting

ESD

Sponsor:

AdventHealth

Code:

NCT05468008

Conditions

Esophageal Lesion

Barrett Esophagus

Gastrointestinal Lesions

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Endoscopic Submucosal Dissection

Study Details

Brief summary:

This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic submucosal dissection. All patients will receive standard of medical care and no experimental interventions will be performed.

Conditions

Esophageal Lesion

Barrett Esophagus

Gastrointestinal Lesions

Study ID

NCT05468008

Start date

Feb 4, 2022

Status verified date

Jan, 2026

Completion date

Dec, 2027

Anticipated

Primary completion date

Feb, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age 18 years or older
  • Scheduled to undergo ESD

Exclusion Criteria:

  • Any contraindication to performing endoscopy
  • Participation in another research protocol that could interfere or influence the outcomes measures of the present study.

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Interventions

Endoscopic Submucosal Dissection

Endoscopic submucosal dissection (ESD) is an outpatient procedure to remove deep tumors from the gastrointestinal (GI) tract

Primary outcome measure

  • Evaluate the utility of ESD for treatment of gastrointestinal lesions [ Time Frame: 12 months ]

Central Contacts and Locations

Central contacts

Dennis Yang, MD

407-303-2570Dennis.Yang.MD@adventhealth.com

Locations

AdventHealth Orlando

Recruiting

Orlando, Florida, United States, 32803

Contacts

Dennis Yang, MD

407-303-2570Dennis.Yang.MD@adventhealth.com

More Information

Sponsor

AdventHealth

Last update posted

Feb 2, 2026

Last verified

Jan, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by AdventHealth on 2026-02-02.